Clinical Trial Update: Mangosteen Supplement as Adjuvant Therapy With Sitagliptin/Metformin in Iraqi Patients With Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluating mangosteen supplement as an adjuvant to sitagliptin/metformin in Iraqi patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Insulin Resistance
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Mangosteen supplement
• Sitagliptin/metformin (sitagliptin/metformin)

Snippet

Sponsor: Mais Qais Hbeeb | Conditions: Diabete Mellitus, Type 2 Diabetes | NA | Status: COMPLETED